H. Guy

967 total citations · 1 hit paper
10 papers, 653 citations indexed

About

H. Guy is a scholar working on Oncology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, H. Guy has authored 10 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in H. Guy's work include Neutropenia and Cancer Infections (5 papers), Antifungal resistance and susceptibility (5 papers) and Cancer therapeutics and mechanisms (2 papers). H. Guy is often cited by papers focused on Neutropenia and Cancer Infections (5 papers), Antifungal resistance and susceptibility (5 papers) and Cancer therapeutics and mechanisms (2 papers). H. Guy collaborates with scholars based in France and Switzerland. H. Guy's co-authors include Éric Solary, Olivier Casasnovas, B. Cuisenier, Alain Bonnin, Alain Bernard, J.F. Couaillier, D. Caillot, Monique Dumas, F Piard and Tony Petrella and has published in prestigious journals such as Journal of Clinical Oncology, Leukemia and Journal of Infection.

In The Last Decade

H. Guy

10 papers receiving 623 citations

Hit Papers

Improved management of invasive pulmonary aspergillosis i... 1997 2026 2006 2016 1997 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Guy France 6 495 464 162 83 82 10 653
Angelika Boehme Germany 5 525 1.1× 480 1.0× 152 0.9× 50 0.6× 88 1.1× 8 653
Julie M. Bryar United States 7 400 0.8× 436 0.9× 111 0.7× 44 0.5× 39 0.5× 9 544
Wellington Morais de Azevedo Brazil 6 849 1.7× 799 1.7× 247 1.5× 97 1.2× 104 1.3× 10 1.0k
Virginie Gandemer France 6 267 0.5× 243 0.5× 42 0.3× 61 0.7× 45 0.5× 17 457
A. Wilmer Belgium 4 366 0.7× 364 0.8× 146 0.9× 38 0.5× 39 0.5× 4 450
S P Dix United States 9 177 0.4× 129 0.3× 121 0.7× 38 0.5× 13 0.2× 9 595
Corinna Hahn‐Ast Germany 13 188 0.4× 187 0.4× 201 1.2× 25 0.3× 12 0.1× 22 492
Daniela Tacke Germany 8 264 0.5× 222 0.5× 94 0.6× 24 0.3× 20 0.2× 8 362
Mitsuo Kitahara United States 11 138 0.3× 117 0.3× 24 0.1× 21 0.3× 40 0.5× 19 350
Joseph J. Nania United States 6 351 0.7× 320 0.7× 86 0.5× 60 0.7× 19 0.2× 6 410

Countries citing papers authored by H. Guy

Since Specialization
Citations

This map shows the geographic impact of H. Guy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Guy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Guy more than expected).

Fields of papers citing papers by H. Guy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Guy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Guy. The network helps show where H. Guy may publish in the future.

Co-authorship network of co-authors of H. Guy

This figure shows the co-authorship network connecting the top 25 collaborators of H. Guy. A scholar is included among the top collaborators of H. Guy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Guy. H. Guy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Solary, Éric, Lionel Mannone, Denis Caillot, et al.. (2000). Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes. Leukemia. 14(12). 2085–2094. 20 indexed citations
2.
Caillot, Denis, Alain Bernard, J.F. Couaillier, et al.. (1998). Stratégies diagnostique et thérapeutique dans les aspergilloses pulmonaires invasives des patients atteints d’hémopathies malignes*. Médecine et Maladies Infectieuses. 28(5). 474–484. 2 indexed citations
3.
Caillot, D., Olivier Casasnovas, Alain Bernard, et al.. (1997). Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.. Journal of Clinical Oncology. 15(1). 139–147. 514 indexed citations breakdown →
4.
Bonnotte, Bernard, Denis Caillot, Éric Solary, et al.. (1994). Breakthrough candidemias in patients with haematological malignancies during antifungal azole prophylaxis. A report of 20 cases. Journal of Infection. 28. 59–59. 1 indexed citations
5.
Caillot, Denis, P. Chavanet, Olivier Casasnovas, et al.. (1992). Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B. European Journal of Clinical Microbiology & Infectious Diseases. 11(8). 722–725. 29 indexed citations
6.
Caillot, Denis, Olivier Casasnovas, Éric Solary, et al.. (1992). Itraconazole as Salvage Therapy in Invasive Pulmonary Aspergillosis Occurring during Amphotericin B Therapy in Neutropenic Patients. Chemotherapy. 38(1). 50–51. 4 indexed citations
7.
Fenaux, Pierre, G. Tertian, Sylvie Castaigné, et al.. (1991). A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia.. Journal of Clinical Oncology. 9(9). 1556–1561. 44 indexed citations
8.
Solary, Éric, Bruno Chauffert, Denis Caillot, et al.. (1990). Quinine circumvents the doxorubicin resistance of a multidrug resistant human leukemic cell-line, K562/DXR.. PubMed. 32(5). 361–3. 5 indexed citations
9.
Harousseau, Jean‐Luc, et al.. (1989). Treatment of acute myeloid leukemia in elderly patients with oral idarubicin as a single agent. European Journal Of Haematology. 42(2). 182–185. 32 indexed citations
10.
Guy, H., et al.. (1987). [Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)].. PubMed. 16(43). 2172–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026